‘åŠwƒz[ƒ€ >> ‹³ˆõÐ‰î

| ŠO’r Œõ—Y | –Ø‘º ”\Í | ÷ˆä “Ä | …’J —zˆê | ŒÜ\—’ ˜N | ‹{è _ | ŽRí• NË |

| ‹e’r “µ | ŒS T•½ | V“c ‰À”Œ | —Ñ ‘ñ¢ | ”¨’† —R‰À | Î–ì ’¼–¾ |

ŠO’r   Œõ—YiTonoike Mitsuoj

XV“ú2011.8.12
Ž–¼
iŠ¿ŽšjŠO’r   Œõ—Y
iƒJƒijƒgƒmƒCƒP   ƒ~ƒcƒI
iRomanjMitsuo   Tonoike
Š‘®—•–ì‘åŠwˆã—Õی’Šw•”   —Տ°HŠw‰È
E–¼‹³Žö
˜A—æZŠi567-0012j   ‘åã•{ˆï–ØŽs“Œ‘¾“c4-5-4
Tel072-627-1711   i“àü”ԍ†F94-212j
FAX072-627-1753
Mail
Šw—ð
”NŒŽ‘åŠwEŠw•”EŠw‰ÈE‘åŠw‰@EêU–¼
1967.3Ã‰ª‘åŠw•¶—Šw•”—Šw‰È   •¨—ŠwêU@‘²
E—ð
A”C“ú‘Þ”C“ú‹@ŠÖ–¼EE–¼E–ðE–¼
2011.4ŠwZ–@l—•–ìŠw‰@—•–ì‘åŠwˆã—Õی’Šw•”—Տ°HŠw‰È   ‹³Žö
2010.42011.3ç—t‘åŠw‘åŠw‰@HŠwŒ¤‹†‰È   ‹qˆõ‹³Žö
2007.42010.3ç—t‘åŠw‘åŠw‰@HŠwŒ¤‹†‰ÈlHƒVƒXƒeƒ€‰ÈŠwêUƒƒfƒBƒJƒ‹ƒVƒXƒeƒ€ƒR[ƒX   ‹³Žö
2005.42007.3ç—t‘åŠwHŠw•”ƒƒfƒBƒJƒ‹ƒVƒXƒeƒ€HŠw‰È   ‹³Žö
2004.42005.3i“ƁjŽY‹Æ‹Zp‘‡Œ¤‹†ŠlŠÔ•ŸŽƒˆãHŠwŒ¤‹†•”–å‚­‚炵î•ñHŠwƒOƒ‹[ƒv   Žå”CŒ¤‹†ˆõ
2001.42004.3i“ƁjŽY‹Æ‹Zp‘‡Œ¤‹†Šƒ‰ƒCƒtƒGƒŒƒNƒgƒƒjƒNƒXŒ¤‹†ƒ‰ƒ{   •›Œ¤‹†ƒ‰ƒ{’·
1995.42001.3i“ƁjŽY‹Æ‹Zp‘‡Œ¤‹†Š‘åãƒ‰ƒCƒtƒGƒŒƒNƒgƒƒjƒNƒXŒ¤‹†ƒZƒ“ƒ^[¶‘̃GƒŒƒNƒgƒƒjƒNƒXŒ¤‹†Žº   Žº’·
1988.41995.3“dŽq‹Zp‘‡Œ¤‹†Š‘åãŽxŠŽY‹ÆŒv‘ªŒ¤‹†Žº   Žå”CŒ¤‹†Š¯
1967.41988.3’ʏ¤ŽY‹ÆÈH‹Æ‹Zp‰@“d‹CŽŽŒ±Š‘åãŽxŠ“üŠ   Œ¤‹†ˆõ
Žæ“¾ŠwˆÊHŠw”ŽŽmy‘åã‘åŠwz
Ž‘ŠiE–Æ‹–
”NŒŽŠT—v
2001.1‰q¶HŠw‰q¶ŠÇ—Žm   Žæ“¾
’S“–‰È–Ú
1”N2”N3”N4”N
“d‹CHŠwI
“d‹CHŠwII
Œv‘ªHŠw
ˆã—pM†E‰æ‘œˆ—
-
‘²‹ÆŒ¤‹†
ê–啪–ì”]_Œo‰ÈŠwE—Z‡”]Œv‘ª‰ÈŠwClŠÔˆãHŠwEˆã—p¶‘̍HŠwC”ñNP”]Œv‘ªŠwCŠ´Šo¶—Šw
Š‘®Šw‰ï—Տ°_Œo¶—Šw‰ïC“ú–{¶‘̈ãHŠw‰ïC“dŽqî•ñ’ʐMŠw‰ïC“ú–{¶‘ÌŽ¥‹CŠw‰ïC“ú–{–¡‚Æ“õŠw‰ïC“ú–{‚u‚qŠw‰ï
Œ¤‹†ƒe[ƒ}”ñNPƒ}ƒ‹ƒ`ƒ‚[ƒ_ƒ‹¶‘ÌŒv‘ªŽè–@‚ÌŒ¤‹†Cƒqƒg‚̌܊´‚ÌŠ´Šoî•ñ“‡‹@”\‚ÌŒ¤‹†Cƒqƒg‚̍‚ŽŸ”]‹@”\‚̉𖾂Ɋւ·‚錤‹†
‹ÆÑ
Ží•Ê‘è–ÚŒfÚŽ–¼C‹@ŠÖ–¼“™”­s”NŒŽ
˜_•¶Odors activate selectively the brain areas related on the memory and emotion, by an fMRI studyClinical Neurophsiology, 121, Suppl.12010
˜_•¶Objective detection of the flicker fusion threshold with pupil diameter and visual evoked magnetic fieldAdvances in Biomagnetism , Springer, pp.334-3372010
˜_•¶škŠo‰ž“š‚ªŠÖ˜A‚·‚éî“®‚ւ̉e‹¿@[‹@”\“IMRIŒ¤‹†¶‘̈ãHŠwC48(‚P)C59-652010
˜_•¶’†•«škŠoáŠQ‚Ì‘¼Šo“If’f–@‚ÌŠm—§‚ð–ÚŽw‚µ‚½škŠo‰ž“š‚ÌŒv‘ª‚ƉðÍ“d‹CŠw‰ï˜_•¶Ž‚bC130 (8), 1379-13862010
˜_•¶ˆ³‘—•ûŽ®‚É‚æ‚éEvent-related MRI‚ð—p‚¢‚½škŠo‚̍‚ŽŸ”]‹@”\Œv‘ª“ú–{VRŠw‰ïŒ¤‹†•ñC14CCS-2C39-442009
˜_•¶Category-related responses of face revealed by the measurements using MEG and fMRIProceedings of 16th Int. Conf. on Biomagnetism, Hokkaido Yniv. Press2008
’˜‘Š´ŠoEŠ´î‚ƃƒ{ƒbƒg“ú–{‹@ŠBŠw‰ï•ÒCH‹Æ’²¸‰ïi‹¤’˜j2008
’˜‘—Տ°_Œo¶—ŒŸ¸‚ÌŽÀÛ¼‰Y‰ël•ÒCV‹»ˆãŠwo”ŎЁi‹¤’˜j2007
˜_•¶Cortical representation of taste-modifying action of miracle fruit in humansNeuro ImageC33 (4)C1145-11512006
˜_•¶Reactivation of physical motor information in the memory of action eventsBrain ResarchC1101(26)C102-1092006
’˜‘‚É‚¨‚¢‚Æ”]Es“®ŠO’rŒõ—YEa’J’B–¾•Ò’˜CƒtƒŒƒOƒ‰ƒ“ƒXƒWƒƒ[ƒiƒ‹ŽÐi‹¤’˜j2003
Šw‰ïŠˆ“®
A”C“ú‘Þ”C“ú‹@ŠÖ–¼E–ðE–¼
2007.4“ú–{VRŠw‰ïu‚è‚Ɛ¶‘̏î•ñŒ¤‹†‰ïvŠ²Ž–E•›ˆÏˆõ’·
2007.42010.3“ú–{¶‘ÌŽ¥‹CŠw‰ïŠ²Ž–E•›‰ï’·
2005.42007.3“dŽqî•ñ’ʐMŠw‰ïî•ñƒ\ƒTƒCƒGƒeƒBŽ•ÒWˆÏˆõ‰ïˆÏˆõ
1999.42005.3“dŽqî•ñ’ʐMŠw‰ïME‚ƃTƒCƒoƒlƒeƒBƒbƒNƒXŒ¤‹†ê–åˆÏˆõ‰ïˆÏˆõ
1992.4“ú–{—Տ°_Œo¶—Šw‰ï•]‹cˆõ
1991.42011.3Œv‘ªŽ©“®§ŒäŠw‰ï¶‘̐¶—HŠw•”‰ïŠ²Ž–
1990.42001.3“ú–{–¡‚Æ“õŠw‰ï‰^‰cˆÏˆõE•ÒWˆÏˆõ’·EŽ–±Š²Ž–
ŽÐ‰ï“IŠˆ“®
A”C“ú‘Þ”C“ú‹@ŠÖ–¼E–ðE–¼
2011.4ç—t‘åŠwƒtƒƒ“ƒeƒBƒAƒƒfƒBƒJƒ‹HŠwŒ¤‹†ŠJ”­ƒZƒ“ƒ^[“Á•Ê‹³Žö
2010.4ç—t‘åŠwƒOƒ‰ƒ“ƒhƒtƒFƒ[
2010.4“Œ–k‘åŠw“d‹C’ʐMŒ¤‹†ŠuƒuƒŒƒCƒ“EƒEƒGƒAvŒ¤‹†ƒvƒƒWƒFƒNƒgˆÏˆõ
2007.4‚É‚¨‚¢E‚èŠÂ‹«‹¦‰ïuŠ¯”\•]‰¿ŒŸ“¢ˆÏˆõ‰ïvˆÏˆõ
2004.4ŒoÏŽY‹ÆÈ’nˆæ‹ZpŠJ”­Ž–‹Æ‚ÉŒW‚鎖‘O’²¸ˆÏˆõ‰ïˆÏˆõ
2004.42007.3L‹C”»’èŽm‘‰ÆŽ‘ŠiŽŽŒ±ˆÏˆõ‰ïˆÏˆõ
2004.1Aroma ResarchŽ•ÒWˆÏˆõ‰ïˆÏˆõ
2003.4•ºŒÉŒ§ŽY‹Æ”pŠü•¨ˆ—‚ÉŠÖ‚·‚éê–å’²¸ˆÏˆõ‰ïˆÏˆõ
2003.42007.4‘ÛHFSPˆÏˆõ‰ïEHFSPƒvƒƒOƒ‰ƒ€R¸ˆÏˆõ‰ïƒ[ƒ‹ƒŒƒrƒ…[ƒA[
1993.42001.3‘å‘ ÈŠÖÅ‹ÇŒ¤‹†”ǁE•ª‰È‰ïê–åˆÏˆõ
1991.41995.3(àj“ú–{ŽY‹Æ‹ZpU‹»‹¦‰ïulŠÔ¶Šˆ‰ÈŠw’²¸ˆÏˆõ‰ïvˆÏˆõ
ŽóÜ
”NŒŽŠT—v
2005.7‘æ20‰ñ“ú–{¶‘ÌŽ¥‹CŠw‰ï‘å‰ïŒ¤‹†§—ãÜŽóÜ
2004.92004”N“ú–{‰¹‹¿Šw‰ïH‹G‘å‰ï@‘æ12‰ñ—DGƒ|ƒXƒ^[ÜŽóÜ
1999.12ƒhƒCƒcErlangen‘åŠw¶—‰ÈŠwEˆãŠw‹¦‰ïEŠwpvŒ£ÜiŠOl‚Ì•”jŽóÜ
“Á‹–“™
”NŒŽŠT—v
2010.6“Á‹–@‘æ4532987 u¶‘Ì‹@”\‰ðÍƒVƒXƒeƒ€C¶‘Ì‹@”\‰ðÍ‘•’uC‚¨‚æ‚ѐ¶‘Ì‹@”\‰ðÍ•û–@v
2009.6“Á‹–@‘æ4304307 uˆã—×pŠí‹ïv
2005.7“Á‹–@‘æ3702337 u–¡ƒpƒ‹ƒXŽhŒƒ‘•’uv
2005.4“Á‹–@‘æ3665816 u–¡ŽhŒƒƒ}ƒEƒXƒs[ƒXv
2003.11“Á‹–@‘æ3497833 u’®‰¹”g‘Ì“`“±’®ŠoŠív
2003.4“Á‹–@‘æ3422417 u‘Ì“`“±’®ŠoŠív
2001.2“Á‹–@‘æ3155979 uškŠo”FŽ¯”»’è‘•’uv
ŽÐ‰ïŠˆ“®‚ÌŽÀÑ
”NŒŽŠT—v
2010.8ƒTƒCƒGƒ“ƒXEƒ`ƒƒƒ“ƒlƒ‹TV@ u‘Ì‚Ì’†‚ðŒ©‚é•û–@v@ “õ‚¢‚ÌfMRIŒv‘ª
2010.6‚m‚g‚j‹³ˆçTV uƒTƒCƒGƒ“ƒXEƒ[ƒv@ŒÜŠ´‚Ì–À‹{@škŠo
2010.6ƒtƒW‚s‚u@@ u‚ß‚´‚Ü‚µ“y—j“úv@@‚è‚Æ‹L‰¯
2010.2‚m‚g‚j‘‡TV u‚䂤‚Ç‚«ƒlƒbƒgƒ[ƒNv@@‚èƒrƒWƒlƒX
ˆêŒ¾w—LŒ¾ŽÀsxCwŒÕŒŠ‚É“ü‚炸‚ñ‚ΌՎ™‚𓾂¸x
ŒÂlƒz[ƒ€ƒy[ƒW

[TOP‚É–ß‚é]

–Ø‘º   ”\ÍiYoshiaki Kimuraj

XV“ú2010.5.13
Ž–¼
iŠ¿Žšj–Ø‘º   ”\Í
iƒJƒijƒLƒ€ƒ‰   ƒˆƒVƒAƒL
iRomanjYoshiaki   Kimura
Š‘®—•–ì‘åŠwˆã—Õی’Šw•”   —Տ°HŠw‰È
E–¼‹³Žö
˜A—æZŠi567-0012j   ‘åã•{ˆï–ØŽs“Œ‘¾“c4-5-4
Tel072-627-1711   i“àü”ԍ†F94-220j
FAX072-627-1753
Mail
Šw—ð
”NŒŽ‘åŠwEŠw•”EŠw‰ÈE‘åŠw‰@EêU–¼
-
E—ð
A”C“ú‘Þ”C“ú‹@ŠÖ–¼EE–¼E–ðE–¼
2010.4—•–ì‘åŠwˆã—Õی’Šw•”—Տ°HŠw‰È   ‹³Žö
Žæ“¾ŠwˆÊ
Ž‘ŠiE–Æ‹–
”NŒŽŠT—v
-
’S“–‰È–Ú
1”N2”N3”N4”N
-
ê–啪–ì-
Š‘®Šw‰ï-
Œ¤‹†ƒe[ƒ}-
‹ÆÑ
Ží•Ê‘è–ÚŒfÚŽ–¼C‹@ŠÖ–¼“™”­s”NŒŽ
-
“Á‹–“™
”NŒŽŠT—v
-
ˆêŒ¾
ŒÂlƒz[ƒ€ƒy[ƒW

[TOP‚É–ß‚é]

÷ˆä   “āiAtsushi Sakuraij

XV“ú2010.5.17
Ž–¼
iŠ¿Žšj÷ˆä   “Ä
iƒJƒijƒTƒNƒ‰ƒC   ƒAƒcƒV
iRomanjAtsushi   Sakurai
Š‘®—•–ì‘åŠwˆã—Õی’Šw•”   —Տ°HŠw‰È
E–¼‹³Žö
˜A—æZŠi567-0012j   ‘åã•{ˆï–ØŽs“Œ‘¾“c4-5-4
Tel072-627-1711   i“àü”ԍ†F94-230j
FAX072-627-1753
Mail
Šw—ð
”NŒŽ‘åŠwEŠw•”EŠw‰ÈE‘åŠw‰@EêU–¼
1983.3ŠÖ¼‘åŠw‘åŠw‰@HŠwŒ¤‹†‰È‹@ŠBHŠwêU”ŽŽm‰Û’ö‘OŠú‰Û’ö   C—¹
1981.3ŠÖ¼‘åŠwHŠw•”‹@ŠBHŠw‘æ‚QŠw‰È   ‘²‹Æ
E—ð
A”C“ú‘Þ”C“ú‹@ŠÖ–¼EE–¼E–ðE–¼
2010.4—•–ì‘åŠwˆã—Õی’Šw•”—Տ°HŠw‰È   ‹³Žö
2000.4ŠÖ¼‘åŠwHŠw•”‹@ŠBƒVƒXƒeƒ€HŠw‰È   ê”CuŽt
1983.4ŠÖ¼‘åŠwHŠw•”‹@ŠBHŠw‘æ‚QŠw‰È   •Žè
Žæ“¾ŠwˆÊ”ŽŽmiHŠwjyŠÖ¼‘åŠwz
Ž‘ŠiE–Æ‹–
”NŒŽŠT—v
-
’S“–‰È–Ú
1”N2”N3”N4”N
”ŠwE•¨—Šw‰‰K
‹@ŠBHŠw
‹@ŠBHŠw‰‰K
‹@ŠBHŠwŽÀK
ˆã—pÞ—¿Šw
—Տ°HŠw‘‡‰‰K
‘²‹ÆŒ¤‹†
ê–啪–ì‹@ŠBHŠwC—¬‘̍HŠwClŠÔˆãHŠw
Š‘®Šw‰ï“ú–{‹@ŠBŠw‰ïC“ú–{ƒoƒCƒIƒŒƒIƒƒW[Šw‰ïC‰ÂŽ‹‰»î•ñŠw‰ïC“ú–{¬‘Š—¬Šw‰ï
Œ¤‹†ƒe[ƒ}ŒŒŠÇ‚ð–Í‹[‚µ‚½_‚ç‚©‚¢E‚‚ԂêˆÕ‚¢’e«ŠÇ“à‚Ì—¬‚êCŒŒ‹…‚ð–Í‹[‚µ‚½_“î’e«ƒQƒ‹”÷—±Žq‚Ì‘n»
‹ÆÑ
Ží•Ê‘è–ÚŒfÚŽ–¼C‹@ŠÖ–¼“™”­s”NŒŽ
˜_•¶lH•Ù’uŠ·Žž‚̍œK‚È‘å“®–¬Šî•”Œ`ó‚ÉŠÖ‚·‚é\‘¢‰ðÍ-SŠg’£Šú‚ɍì—p‚·‚鈳—Í•‰‰×‚Ì‚Ý‚ðl—¶‚µ‚½\‘¢‰ðÍ-¶‘̈ãHŠwC47Šª1†2009
‘Û‰ï‹cDevelopment of fine alginate gel particles as model/artificial blood cells and measurement of its elastic characteristics5th World Congress of Biomechanics, Munich2006
˜_•¶Stents Cause Flow Disturbances in Cornary Arteries: A Study using Laser-Doppler-Anemometry (LDA)Cardiovascular Engineering, Vol.10, No.12005
‘Û‰ï‹cFlow Visualization and LDA Velocity Measurement in Models with Stents of Carotid Arteries10th Int. Symp. on Flow Visualization, Kyoto2002
˜_•¶Numerical Simulation and Experimental Verification of Wave Propagation in a Collapsible TubeJSME International Journal, Series C, Vol. 42, No.31999
“Á‹–“™
”NŒŽŠT—v
-
ˆêŒ¾
ŒÂlƒz[ƒ€ƒy[ƒW

[TOP‚É–ß‚é]

“c’†   r“TiToshifumi Tanakaj

XV“ú2010.5.13
Ž–¼
iŠ¿Žšj“c’†   r“T
iƒJƒijƒ^ƒiƒJ   ƒgƒVƒtƒ~
iRomanjToshifumi   Tanaka
Š‘®—•–ì‘åŠwˆã—Õی’Šw•”   —Տ°HŠw‰È
E–¼‹³Žö
˜A—æZŠi567-0012j   ‘åã•{ˆï–ØŽs“Œ‘¾“c4-5-4
Tel072-627-1711   i“àü”ԍ†F94-201j
FAX072-627-1753
Mail
Šw—ð
”NŒŽ‘åŠwEŠw•”EŠw‰ÈE‘åŠw‰@EêU–¼
1991.3‘åãˆã‰È‘åŠw—Տ°Œn‘åŠw‰@   ’PˆÊŽæ“¾‘ÞŠw
1984.3‘åãˆã‰È‘åŠwˆãŠw•”ˆãŠw‰È   ‘²‹Æ
E—ð
A”C“ú‘Þ”C“ú‹@ŠÖ–¼EE–¼E–ðE–¼
2010.4—•–ì‘åŠwˆã—Õی’Šw•”—Տ°HŠw‰È   ‹³Žö
Žæ“¾ŠwˆÊˆãŠw”ŽŽmy‘åãˆã‰È‘åŠwz
Ž‘ŠiE–Æ‹–
”NŒŽŠT—v
XXXX.XX.XXˆãŽt–Æ‹–@Žæ“¾
’S“–‰È–Ú
1”N2”N3”N4”N
ˆãŠwŠT˜_
—Տ°ˆãŠw‘˜_I
ê–啪–ì“à‰ÈŠwC_Œo“à‰ÈŠw
Š‘®Šw‰ï“ú–{“à‰ÈŠw‰ïC“ú–{_ŒoŠw‰ïC“ú–{˜V”NˆãŠw‰ïC“ú–{“Œ—mˆãŠw‰ïC“ú–{ˆã—Ïî•ñŠw‰ï
Œ¤‹†ƒe[ƒ}‹ØƒWƒXƒgƒƒtƒB[‚ÌŽ¡—ÂɊւ·‚錤‹†CƒMƒ‰ƒ“ƒoƒŒ[ÇŒóŒQ‚Ì•aˆö‚ɂ‚¢‚Ä
‹ÆÑ
Ží•Ê‘è–ÚŒfÚŽ–¼C‹@ŠÖ–¼“™”­s”NŒŽ
˜_•¶Possible de novo CTG repeat expansion in DMPK gene of a patient with cardiomyopathyJournal of Clinical Neuroscience2010
Šw‰ï”­•\‹Ø‹­’¼«ƒWƒXƒgƒƒtƒB[‚É‚¨‚¯‚éƒXƒvƒ‰ƒCƒVƒ“ƒOˆÙí‚̊ȕւȃXƒNƒŠ[ƒjƒ“ƒO–@‚ÌŠJ”­‘æ49‰ñ“ú–{_ŒoŠw‰ï‘‰ï2008
˜_•¶Biological roles of anti-GM1 antibodies in patients with Guillain-Barré syndrome for nerve growth factor signalingBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease2007
Šw‰ï”­•\Visualization of the alternative splicing in living cells6th The International Myotonic Dystrophy Consortium Meeting (IDMC6)2007
“Á‹–“™
”NŒŽŠT—v
-
ˆêŒ¾
ŒÂlƒz[ƒ€ƒy[ƒW

[TOP‚É–ß‚é]

…’J   —zˆêiYoichi Mizutanij

XV“ú2015.6.1
Ž–¼
iŠ¿Žšj…’J   —zˆê
iƒJƒijƒ~ƒYƒ^ƒj   ƒˆƒEƒCƒ`
iRomanjYoichi   Mizutani
Š‘®—•–ì‘åŠwˆã—Õی’Šw•”   —Տ°HŠw‰È
E–¼‹³ŽöEŠw‰È’·•â²
˜A—æZŠi567-0012j   ‘åã•{ˆï–ØŽs“Œ‘¾“c4-5-4
Tel072-627-1711   i“àü”ԍ†F94-220j
FAX072-627-1753
Mail
Šw—ð
”NŒŽ‘åŠwEŠw•”EŠw‰ÈE‘åŠw‰@EêU–¼
1992.3‹ž“s‘åŠw‘åŠw‰@ˆãŠwŒ¤‹†‰ÈŠO‰ÈŒnêU”ŽŽm‰Û’ö   C—¹
1985.3‹ž“s‘åŠwˆãŠw•”   ‘²‹Æ
E—ð
A”C“ú‘Þ”C“ú‹@ŠÖ–¼EE–¼E–ðE–¼
2012.4—•–ì‘åŠwˆã—Õی’Šw•”—Տ°HŠw‰È   ‹³Žö
2006.42010.3–¼ŒÃ‰®‘åŠwˆãŠw•”   ”ñí‹ÎuŽt
2004.62009.3‹ž“s•{—§ˆã‰È‘åŠw”å”AŠí‰È   y‹³Žö
1999.112004.5‹ž“s•{—§ˆã‰È‘åŠw”å”AŠí‰È   uŽt
1998.1•Ä‘ƒJƒŠƒtƒHƒ‹ƒjƒA‘åŠwƒƒTƒ“ƒ[ƒ‹ƒXZˆãŠw•”–ƉuE”÷¶•¨ŠwE•ªŽqˆâ“`Šw‰È   ‹qˆõ‹³Žö
1992.91999.8‹ž“s‘åŠwˆãŠw•””å”AŠí‰È   •Žè
1991.41992.8•Ä‘ƒJƒŠƒtƒHƒ‹ƒjƒA‘åŠwƒƒTƒ“ƒ[ƒ‹ƒXZˆãŠw•”–ƉuE”÷¶•¨ŠwE•ªŽqˆâ“`Šw‰È   ‹qˆõŒ¤‹†ˆõ
Žæ“¾ŠwˆÊ”ŽŽmiˆãŠwjy‹ž“s‘åŠwz
Ž‘ŠiE–Æ‹–
”NŒŽŠT—v
2009.12—Տ°C—ûŽw“±ˆãi‘æ2836†j@Žæ“¾
2008.9“ú–{‚ª‚ñŽ¡—ÔF’è‹@\”F’èˆãi‘æ07200546†j@Žæ“¾
2007.8“ú–{‚ª‚ñŽ¡—ÔF’è‹@\Žb’苳ˆçˆãi‘æ070422†j@Žæ“¾
2005.4“ú–{”å”AŠí‰ÈŠw‰ïE“ú–{”å”AŠí“àŽ‹‹¾Šw‰ï”å”AŠí• o‹¾‹Zp”F’èˆãi‘æ05-107-2†j@Žæ“¾
2005.1“ú–{“àŽ‹‹¾ŠO‰ÈŠw‰ï‹Zp”F’èˆãi”å”AŠí• o‹¾ji‘æ05-EE-061†j@Žæ“¾
2001.8“ú–{ŠàŽ¡—Êw‰ï—Տ°ŽŽŒ±“o˜^ˆãi‘æ0011†j@Žæ“¾
1995.4“ú–{”å”AŠí‰ÈŠw‰ïŽw“±ˆãi‘æ950204†j@Žæ“¾
1990.1“ú–{”å”AŠí‰ÈŠw‰ïê–åˆãi‘æ900220†j@Žæ“¾
1985.5ˆãŽt–Æ‹–i‘æ289089†j@Žæ“¾
’S“–‰È–Ú
1”N2”N3”N4”N
Œ’N‰ÈŠw
tE”å”AŠí‰ÈŠw
—Տ°HŠw‰È“Á•Ê‰‰K
•a‘ÔŠw
‰p•¶´“Ç
‘²‹ÆŒ¤‹†
—Տ°HŠw“Á˜_
ê–啪–ìŽîᇊwC”å”AŠí‰ÈŠwC—Տ°HŠw
Š‘®Šw‰ï“ú–{ŠàŠw‰ïA“ú–{ŠàŽ¡—Êw‰ïA“ú–{”å”AŠí‰ÈŠw‰ïA“ú–{“àŽ‹‹¾ŠO‰ÈŠw‰ïA“ú–{”å”AŠí“àŽ‹‹¾Šw‰ïA•Ä‘ŠàŠw‰ïA•Ä‘—Տ°Žîᇊw‰ïA•Ä‘”å”AŠí‰ÈŠw‰ï
Œ¤‹†ƒe[ƒ}Šà‚ɑ΂·‚镪Žqf’fE•ªŽq•W“IŽ¡—ÁAƒAƒ|ƒg[ƒVƒX—U“±‚É‚æ‚éŠàŽ¡—ÁAŠà‚ɑ΂·‚éˆâ“`ŽqŽ¡—ÁAŠà‚ɑ΂·‚鉻Šw—Ö@E–Ɖu—Ö@A“§Íˆã—Ã
‹ÆÑ
Ží•Ê‘è–ÚŒfÚŽ–¼C‹@ŠÖ–¼“™”­s”NŒŽ
’˜‘Immunotherapy of Cancer: An Innovative Treatment Comes of Age -BRMs and Crude Agents: BCG.-Springer2015
Šwp˜_•¶Low circulating serum levels of second mitochondria-derived activator of caspase ( Smac/DIABLO ) in patients with bladder cancerInt. J. Oncol., 40, 1246-12502012
’˜‘”å”AŠí‰È—̈æ‚̐f—ÃKƒCƒhƒ‰ƒCƒ“‚̍œŽq”å”AŠí‰Èf—ÃKƒCƒhA‹à–F“°App.434-4582011
’˜‘Šà‰»Šw—Ö@A•úŽËüŽ¡—Ö@A–Ɖu—Ö@A•ªŽq•W“I—Ö@ƒXƒ^ƒfƒBƒƒCƒg”å”AŠí‰ÈŠwA‹à–F“°App.405-4102009
’˜‘ƒXƒ^ƒfƒBƒƒCƒg”å”AŠí‰ÈŠwCˆâ“`ŽqŠwŒŸ¸‹à–F“°2009
’˜‘ƒXƒ^ƒfƒBƒƒCƒg”å”AŠí‰ÈŠwC“à•ª”åŠwŒŸ¸‹à–F“°2009
Šwp˜_•¶Anti-gout agent allopurinol exerts cytotoxicity to human hormone-refractory prostate cancer cells in combination with TRAILMol. Cancer Res., 6, 1852-602008
Šwp˜_•¶Molecular featutes of hormone-refractory prostate cancer cells by genome-wide gene expression profilesCancer Res., 67, 5117-252007
Šwp˜_•¶Expression of X-linked inhibitor of apoptosis protein ( XIAP ) is a stromg predictor of human prostate cancer recurrenceClin. Cancer Res., 13, 6056-632007
’˜‘VE”å”AŠíˆ««Žîᇃ|ƒPƒbƒgƒ}ƒjƒ…ƒAƒ‹C‘O—§‘BŠàƒƒfƒBƒJƒ‹ƒŒƒrƒ…[ŽÐ2006
Šwp˜_•¶Gene therapy with tumor necrosis factor-related apoptosis-inducing ligand ( TRAIL ) against renal cell carcinomaMol. Cancer Ther., 5, 2165-712006
Šwp˜_•¶Downregulation of Smac/DIABLO expression in renal cell carcinoma and its prognostic significanceJ. Clin. Oncol., 23, 448-542005
Šwp˜_•¶Tunicamycin enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human prostate cancer cellsCancer Res., 65, 6364-702005
Šwp˜_•¶Proteasome inhibitor MG132 induces death receptor 5 through CCAAT/enhancer-binding protein homologous proteinCancer Res., 65, 5622-672005
Šwp˜_•¶Prognostic significance of orotate phosphoribosyltransferase activity in bladder cancerCancer, 100, 723-312004
’˜‘ƒŒƒWƒfƒ“ƒg‚Ì‚½‚ß‚Ì”å”AŠíˆ««Žîᇃ|ƒPƒbƒgƒ}ƒjƒ…ƒAƒ‹C‘O—§‘BŠàƒƒfƒBƒJƒ‹ƒŒƒrƒ…[ŽÐ2002
Šw‰ïŠˆ“®
A”C“ú‘Þ”C“ú‹@ŠÖ–¼E–ðE–¼
2008.4-“ú–{”å”AŠí“àŽ‹‹¾Šw‰ï@•]‹cˆõ
2005.42009.3“ú–{”å”AŠí‰ÈŠw‰ï@‘²ŒãE¶ŠUƒR[ƒXˆÏˆõ‰ï@ˆÏˆõ
2005.42009.3“ú–{”å”AŠí‰ÈŠw‰ï@‚ª‚ñ“o˜^„iˆÏˆõ‰ï@äNã÷Šàƒ[ƒLƒ“ƒOƒOƒ‹[ƒv@ˆÏˆõ
2005.42009.3“ú–{”å”AŠí‰ÈŠw‰ï@‹³ˆçˆÏˆõ‰ï@ˆÏˆõ
2003.4tŠàŒ¤‹†‰ï@¢˜bl
2003.42004.3“ú–{”å”AŠí‰ÈŠw‰ï@ê–åˆã§“xR‹c‰ï@’†‰›ˆÏˆõ
2003.42009.3“ú–{”å”AŠí‰ÈŠw‰ï@‚ª‚ñ“o˜^„iˆÏˆõ‰ï@ˆÏˆõ
2002.4-“ú–{“àŽ‹‹¾ŠO‰ÈŠw‰ï@‰ïˆõ
2000.42012.3”å”AŠí‰È•ªŽq×–E‰ðÍŒ¤‹†‰ï@•]‹cˆõ
2000.1-American Society for Clinical Oncology (ASCO)F•Ä‘ŠàŽ¡—Êw‰ï@‰ïˆõ
1996.1-American Urological Association (AUA)F•Ä‘”å”AŠí‰ÈŠw‰ï@‰ïˆõ
1995.4-“ú–{”å”AŠí‰ÈŠw‰ï@ƒ{[ƒeƒBƒ“ƒOƒƒ“ƒo[
1992.1-American Association for Cancer Research (AACR)F•Ä‘ŠàŠw‰ï@‰ïˆõ
1990.4-“ú–{ŠàŽ¡—Êw‰ï@‰ïˆõ
1988.4-“ú–{ŠàŠw‰ï@‰ïˆõ
Žå‚ȎЉ“®“™
A”C“ú‘Þ”C“ú‹@ŠÖ–¼E–ðE–¼
2014.1-Forum on Immunopathological Diseases and Therapeutics•ÒWˆÏˆõ
2013.4-“ú–{—Տ°HŠw‹ZŽm‹³ˆçŽ{Ý‹¦‹c‰ï@Ž{ÝŽÀ–±’S“–ŽÒ
2013.4-“ú–{—Տ°HŠw‹ZŽm‹³ˆçŽ{Ý‹¦‹c‰ï@L•ñˆÏˆõ‰ï
2013.4-Japanese Journal of Clinical Oncology•ÒWˆÏˆõ
2011.4-“ú–{ŠwpU‹»‰ï@‰ÈŠwŒ¤‹†”ïˆÏˆõ‰ïê–åˆÏˆõ
2008.1-Cancer Letters¸“ÇŽÒ
2007.1-Journal of Experimental & Clinical Cancer Research•ÒWˆÏˆõ
2007.1-British Journal of Cancer¸“ÇŽÒ
2006.4-Cancer Science¸“ÇŽÒ
2005.1-European Urology¸“ÇŽÒ
2004.1-Urology¸“ÇŽÒ
2004.1-The Journal of Urology¸“ÇŽÒ
2004.1-Oncology¸“ÇŽÒ
2002.1-Kidney International¸“ÇŽÒ
2002.1-European Journal of Cancer¸“ÇŽÒ
2001.1-CANCER¸“ÇŽÒ
2000.42004.3Cancer Update •ÒWˆÏˆõ
1997.42000.3Biotherapy Today •ÒWˆÏˆõ
1996.1-International Journal of Cancer¸“ÇŽÒ
1995.4-“ú–{”å”AŠí‰ÈŠw‰ïŽGŽ ¸“ÇŽÒ
1995.4-International Journal of Urologyi“ú–{”å”AŠí‰ÈŠw‰ï‰p•¶Žj¸“ÇŽÒ
1994.41999.8”å”AŠí‰È‹I—v •ÒWˆÏˆõ
ŽóÜ
”NŒŽŠT—v
2013.52012”N“xƒAƒƒŠƒJ”å”AŠí‰ÈŠw‰ïŽGŽuThe Journal of UrologyvFBest ReviewerÜi2012 Best Reviewer AwardjŽóÜ
2009.42008”N“xƒAƒƒŠƒJ”å”AŠí‰ÈŠw‰ïŽGŽuThe Journal of UrologyvFBest ReviewerÜi2008 Best Reviewer AwardjŽóÜ
2008.4‘æ96‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ïÜŽóÜ
2006.4‘æ13‰ñ“ú–{”å”AŠí‰ÈŠw‰ïÜŽóÜ
2002.4‘æ11‰ñ“ú–{”å”AŠí‰ÈŠw‰ïŒ¤‹†•¬‹àŽóÜ
1995.4‘æ54‰ñ“ú–{”å”AŠí‰ÈŠw‰ïâŒûÜ
“Á‹–“™
”NŒŽŠT—v
2010.3ƒJƒiƒ_“Á‹–2209124†iAntitumor agent effect enhancer containing IL-6 antagonistj
2008.7“Á‹–4079461†iIL-6ƒAƒ“ƒ^ƒSƒjƒXƒg‚ðŠÜ‚ñ‚Å‚È‚éRŽîᇍ܂̍ì—p‘‹­Üj
2002.3‰¢B“Á‹–0800829†iAntitumor agent effect enhancer containing IL-6 antagonistj
2002.10`“Á‹–HK1001512†iAntitumor agent effect enhancer containing IL-6 antagonistj
2001.11’†‘“Á‹–ZL95197477.7†iAntitumor agent effect enhancer containing IL-6 antagonistj
2000.7ƒAƒƒŠƒJ“Á‹–6086874†iAntitumor agent effect enhancer containing IL-6 antagonistj
2000.1ŠØ‘“Á‹–0252743†iAntitumor agent effect enhancer containing IL-6 antagonistj
1999.8ƒI[ƒXƒgƒ‰ƒŠƒA“Á‹–704723†iAntitumor agent effect enhancer containing IL-6 antagonistj
‚»‚Ì‘¼‚Ì“Á‹LŽ–€
”NŒŽŠT—v
2015.5Medical TribuneŽŒfÚuäNã÷‚ª‚ñ—R—ˆ‚Ì”AL‚Ì‘¶Ý‚ðŽ¦´v
2015.4MTproŒfÚuäNã÷‚ª‚ñ—R—ˆ‚Ì”AL‚Ì‘¶Ý‚ðŽ¦´v
2015.4ŽYŒoV•·ŒfÚuƒ}ƒEƒX‚ÌškŠo@äNã÷‚ª‚ñ”»•Êv
2000.4‹ž“s‘åŠwˆãŠw•”“¯‘‹‰ïŽÅ—–‰ïƒNƒ‰ƒXˆÏˆõ
ˆêŒ¾
ŒÂlƒz[ƒ€ƒy[ƒW

[TOP‚É–ß‚é]

ŒÜ\—’   ˜NiAkira Ikarashij

XV“ú2015.6.16
Ž–¼
iŠ¿ŽšjŒÜ\—’   ˜N
iƒJƒijƒCƒJƒ‰ƒV   ƒAƒLƒ‰
iRomanjAkira   Ikarashi
Š‘®—•–ì‘åŠwˆã—Õی’Šw•”   —Տ°HŠw‰È
E–¼‹³Žö
˜A—æZŠi567-0012j   ‘åã•{ˆï–ØŽs“Œ‘¾“c4-5-4
Tel072-627-1711   i“àü”ԍ†F94-233j
FAX072-627-1753
Mail
Šw—ð
”NŒŽ‘åŠwEŠw•”EŠw‰ÈE‘åŠw‰@EêU–¼
2009.3‹à‘ò‘åŠw‘åŠw‰@Ž©‘R‰ÈŠwŒ¤‹†‰È   ”ŽŽmŒãŠú‰Û’ö   C—¹
2000.4‹à‘ò‘åŠw‘åŠw‰@Ž©‘R‰ÈŠwŒ¤‹†‰È   ”ŽŽmŒãŠú‰Û’ö   “üŠw
E—ð
A”C“ú‘Þ”C“ú‹@ŠÖ–¼EE–¼E–ðE–¼
2014.4—•–ì‘åŠwˆã—Õی’Šw•”—Տ°HŠw‰È   ‹³Žö
2012.42014.3—•–ì‘åŠwˆã—Õی’Šw•”—Տ°HŠw‰È   y‹³Žö
2010.42012.3—•–ì‘åŠwˆã—Õی’Šw•”—Տ°HŠw‰È   uŽt
2009.5‹à‘ò‘åŠw—HŒ¤‹†ˆæ   ”ŽŽmŒ¤‹†ˆõ
2005.10à’c–@lÎìŒ§ŽY‹Æ‘noŽx‰‡‹@\   Œ¤‹†ˆõ
2002.10‰ÈŠw‹ZpU‹»Ž–‹Æ’ciŒ»   “Æ—§s­–@l‰ÈŠw‹ZpU‹»‹@\j   Œ¤‹†ˆõ
1989.4“ú–{“d‹CŠ”Ž®‰ïŽÐ   “üŽÐ
Žæ“¾ŠwˆÊ”ŽŽmiHŠwjy‹à‘ò‘åŠwz
Ž‘ŠiE–Æ‹–
”NŒŽŠT—v
-
’S“–‰È–Ú
1”N2”N3”N4”N
î•ñ‰ÈŠwII
î•ñ‰ÈŠwIII
ˆã—pŽ¡—Ë@ŠíŠwI, II
ˆã—pŽ¡—Ë@ŠíŠwŽÀK
ˆã—p‹@ŠíˆÀ‘SŠÇ—ŠwI. II
ˆã—p‹@ŠíˆÀ‘SŠÇ—ŠwŽÀK
—Տ°HŠw‘‡‰‰K
‘²‹ÆŒ¤‹†
ê–啪–쐶‘̈ãHŠwC•ŸŽƒHŠw
Š‘®Šw‰ï“ú–{¶‘̈ãHŠw‰ïCIEEE Engineering in Medicine&Biology Society
Œ¤‹†ƒe[ƒ}¶‘̏î•ñ‚Ì–³NPE–³S‘©Œv‘ª‹Zp‚ÌŠJ”­Œ¤‹†
‹ÆÑ
Ží•Ê‘è–ÚŒfÚŽ–¼C‹@ŠÖ–¼“™”­s”NŒŽ
’˜‘”ñNPzŠÂ“®‘Ô˜A‘±Œv‘ª‹Zp‚ð—p‚¢‚½‘½—p“r¬Œ^ƒ‚ƒjƒ^ƒVƒXƒeƒ€‚ÌŠJ”­Œ¤‹†”ŽŽm˜_•¶C‹à‘ò‘åŠw2009
Šwp˜_•¶S‘ŸŒŒ‰t‹ìo‚É”º‚¤‹¹•”ƒCƒ“ƒs[ƒ_ƒ“ƒX•Ï‰»ŒŸo‚É‚æ‚é“d‹C“IƒCƒ“ƒs[ƒ_ƒ“ƒXS”o—ÊŒv‘ª—pŽŠ“KƒXƒ|ƒbƒg“d‹É”z’u¶‘̈ãHŠw2008
Prodeedingsi¸“Ç•t‚«j An Improved Local Pressurization-Cuff Technique for Non-invasive Digital Arterial Pressure by the Volume-Compensation Method: Its Performance and Evaluation of AccuracyIFMBE Proceeding2008
Prodeedingsi¸“Ç•t‚«j Experimental and Numerical Study on Optimal spot-electrodes Arrays in Transthoracic Electrical Impedance CardiographyProceedings of the 29th Annual Conference of the IEEE Engineering in Medicine and Biology Society2007
Œ¤‹†•ñ–³NP˜A‘±zŠÂ“®‘Ôƒ‚ƒjƒ^‚ð—p‚¢‚½‹}«ƒXƒgƒŒƒX•‰‰×Žž‚É‚¨‚¯‚éŒÄ‹z—Ö@‚Ì•]‰¿“dŽqî•ñ’ʐMŠw‰ï‹ZpŒ¤‹†•ñ2007
Œ¤‹†•ñ‘SŽ©“®¶‘ÌŒv‘ªƒVƒXƒeƒ€‚ÌŠJ”­‚ƈã—ÃŽx‰‡‚ւ̉ž—p“dŽqî•ñ’ʐMŠw‰ï‹ZpŒ¤‹†•ñ2007
Šwp˜_•¶ŒŒˆ³EŒŒ‰tŽ_‘f–O˜a“x‚Ì–³NP“¯Žžƒ‚ƒjƒ^ƒŠƒ“ƒOƒVƒXƒeƒ€—Տ°ƒ‚ƒjƒ^[1994
“Á‹–“™
”NŒŽŠT—v
2003.5

“Á‹–3880547†iS”o—Ê‘ª’è—p“d‹É‹y‚ѐS”o—Ê‘ª’è‘•’uj

S”o—Ê‘ª’è—p“d‹ÉC‹y‚Ñ‚±‚̐S”o—Ê‘ª’è—p“d‹É‚ð”õ‚¦‚éS”o—Ê‘ª’è‘•’u
1996.8

“Á‹–2956605†iŠ³ŽÒŠÄŽ‹ƒVƒXƒeƒ€j

Š³ŽÒŠÄŽ‹ƒVƒXƒeƒ€‚É‚©‚©‚í‚èC“Á‚ÉŠ³ŽÒ‚ÌŠeŽí¶‘̏î•ñ‚ðŒg‘щ”\‚È–³üŽóM‹@‚É‘—M‚·‚銳ŽÒŠÄŽ‹ƒVƒXƒeƒ€
1992.8

“Á‹–3443688†i”ñŠÏŒŒŒŒˆ³‹y‚ÑŒŒ‰tŽ_‘f–O˜a“x“¯Žž˜A‘±‘ª’è‘•’uj

ŒŒˆ³‹y‚ÑŒŒ‰tŽ_‘f–O˜a“x‚𓯎ž‚ɘA‘±‚µ‚ĈêS”–ˆ‚É‘ª’è‚·‚é”ñŠÏŒŒŒŒˆ³‹y‚ÑŒŒ‰tŽ_‘f–O˜a“x“¯Žž˜A‘±‘ª’è‘•’u
1992.1

“Á‹–2803432†i‡–°Žž–³ŒÄ‹zƒ‚ƒjƒ^j

‡–°Žž–³ŒÄ‹zƒ‚ƒjƒ^‚ÉŠÖ‚µC“Á‚ɔ팱ŽÒ‚𖳍S‘©‚ȏó‘ԂŐ‡–°Žž‚̌ċzM†‚𓾂邱‚Æ‚ª‚Å‚«‚鐇–°Žž–³ŒÄ‹zƒ‚ƒjƒ^
ˆêŒ¾‚¢‚‚łàA‚Ç‚±‚Å‚àŒ’Nƒ`ƒFƒbƒN‚Å‚«‚é‘•’u‚ÌŠJ”­‚ð–ÚŽw‚µ‚Ä‚¢‚Ü‚·B
ŒÂlƒz[ƒ€ƒy[ƒW

[TOP‚É–ß‚é]

‹{è   _iHiroshi Miyazakij

XV“ú2015.10.21
Ž–¼
iŠ¿Žšj‹{è   _
iƒJƒijƒ~ƒ„ƒUƒL   ƒqƒƒV
iRomanjHiroshi   Miyazaki
Š‘®—•–ì‘åŠwˆã—Õی’Šw•”   —Տ°HŠw‰È
E–¼‹³Žö
˜A—æZŠi567-0012j   ‘åã•{ˆï–ØŽs“Œ‘¾“c4-5-4
Tel072-627-1711   i“àü”ԍ†F94-XXXj
FAX072-627-1753
Mail
Šw—ð
”NŒŽ‘åŠwEŠw•”EŠw‰ÈE‘åŠw‰@EêU–¼
1994.3–kŠC“¹‘åŠw ‘åŠw‰@HŠwŒ¤‹†‰È ¶‘̍HŠwêU ”ŽŽmŒãŠú‰Û’ö@C—¹
E—ð
A”C“ú‘Þ”C“ú‹@ŠÖ–¼EE–¼E–ðE–¼
2015.4—•–ì‘åŠwˆã—Õی’Šw•”—Տ°HŠw‰È   ‹³Žö
2009.102015.3‘åã‘åŠw ƒiƒmƒTƒCƒGƒ“ƒXƒfƒUƒCƒ“‹³ˆçŒ¤‹†ƒZƒ“ƒ^[@y‹³Žö iŒ“”Cj
2007.42015.3‘åã‘åŠw ‘åŠw‰@Šî‘bHŠwŒ¤‹†‰È ‹@”\‘n¬êU ¶‘̍HŠw—̈æ@y‹³Žö
2003.42007.3‘åã‘åŠw ‘åŠw‰@Šî‘bHŠwŒ¤‹†‰È ‹@”\‘n¬êU ¶‘̍HŠw—̈æ@•‹³Žö
2002.42003.3‘åã‘åŠw ‘åŠw‰@Šî‘bHŠwŒ¤‹†‰È ƒVƒXƒeƒ€lŠÔŒnêU ‹@ŠB‰ÈŠw•ª–ì@uŽt
1999.92000.8•Ä‘ ƒfƒ…[ƒN‘åŠw ‹qˆõŒ¤‹†ˆõ
1997.42002.3‘åã‘åŠw ‘åŠw‰@Šî‘bHŠwŒ¤‹†‰È ƒVƒXƒeƒ€lŠÔŒnêU ‹@ŠB‰ÈŠw•ª–ì@•Žè
1994.41997.3‘åã‘åŠw Šî‘bHŠw•” ‹@ŠBHŠw‰È@•Žè
Žæ“¾ŠwˆÊ”ŽŽmiHŠwjy–kŠC“¹‘åŠwz
Ž‘ŠiE–Æ‹–
”NŒŽŠT—v
-
’S“–‰È–Ú
1”N2”N3”N4”N
-
¶‘̈ãHŠw
“d‹CHŠwŽÀK
ˆã—pÞ—¿Šw
‰p•¶´“Ç
“dŽqHŠwŽÀK
—Տ°HŠw‘‡‰‰K
‘²‹ÆŒ¤‹†
ê–啪–ìƒoƒCƒIƒƒJƒjƒNƒX
Š‘®Šw‰ï“ú–{lH‘ŸŠíŠw‰ïC“ú–{ƒoƒCƒIƒ}ƒeƒŠƒAƒ‹Šw‰ïC“ú–{‹@ŠBŠw‰ïC“ú–{¶‘̈ãHŠw‰ïC“ú–{ƒoƒCƒIƒŒƒIƒƒW[Šw‰ïC“ú–{Ä¶ˆã—Êw‰ï
Œ¤‹†ƒe[ƒ}×–EƒoƒCƒIƒƒJƒjƒNƒX
‹ÆÑ
Ží•Ê‘è–ÚŒfÚŽ–¼C‹@ŠÖ–¼“™”­s”NŒŽ
’˜‘‘æ1•Ò ‘æ1Í ‘æ1ßu‘gD‚ƍזE‚Ì‘ŠŒÝì—p‚É‚¨‚¯‚éƒoƒCƒIƒƒJƒjƒNƒXvŽOŽŸŒ³ƒeƒBƒbƒVƒ…ƒGƒ“ƒWƒjƒAƒŠƒ“ƒOCƒGƒkEƒeƒB[EƒGƒX, pp. 11-19.2015.2
‘Û‰ï‹cAssessment of nuclear strain imposed by actin filaments in adherent cellsAbstract International Symposium on Mechanobiology 2014, P. 126.2014.5
Šwp˜_•¶i¸“Ç—LjContribution of actin filaments to the global compressive properties of fibroblastsJournal of the Mechanical Behavior of Biomedical Materials, Vol. 14, pp. 192-198.2012
‘Û‰ï‹cComparison of strains in fibroblasts embedded in collagen matrix with applied matrix strainProc. The 4th Asian Pacific Conference on Biomechanics, pp. 172-173.2009
Šwp˜_•¶i¸“Ç—LjMorphological study of fibroblasts treated with cytochalasin D and colchicine using a confocal laser scanning microscopyThe Journal of Physiological Sciences, Vol. 58, No. 7, pp. 499-506.2008
Šwp˜_•¶i¸“Ç—LjTensile properties of contractile and synthetic vascular smooth muscle cellsJSME International Journal, Series C, Vol. 45, No. 4, pp. 870-879.2002
Šwp˜_•¶i¸“Ç—LjEffects of cyclic strain on the morphology and phagocytosis of macrophagesBio-Medical Materials and Engineering, Vol. 11, No. 4, pp. 301-309.2001
Šwp˜_•¶i¸“Ç—LjA newly designed tensile tester for cells and its application to fibroblastsJournal of Biomechanics, Vol. 33, No. 1, pp. 97-104.2000
Šwp˜_•¶i¸“Ç—LjAtomic force microscopic measurement of the mechanical properties of intact endothelial cells in fresh arteriesMedical and Biological Engineering and Computing, Vol. 37, No. 4, pp. 530-536.1999
Šwp˜_•¶i¸“Ç—LjPreliminary study on the effect of substrate size on cellular immunomodulationsArtificial Organs, Vol. 18, No. 10, pp. 740-745.1994
Šw‰ïŠˆ“®
A”C“ú‘Þ”C“ú‹@ŠÖ–¼E–ðE–¼
2013.42015.3“ú–{‹@ŠBŠw‰ï•”–勦‹c‰ï ‚“x•¨—ŽhŒƒ‚Ɛ¶‘̉ž“š‚ÉŠÖ‚·‚錤‹†•ª‰È‰ï ˆÏˆõ
2011.72012.1“ú–{‹@ŠBŠw‰ï ‘æ24‰ñƒoƒCƒIƒGƒ“ƒWƒjƒAƒŠƒ“ƒOu‰‰‰ï ŽÀsˆÏˆõ‰ïˆÏˆõi‘åãj
2011.42012.3“ú–{‹@ŠBŠw‰ï Z‰{ˆÏˆõ
2005.4-“ú–{Ä¶ˆã—Êw‰ï‰ïˆõ
2005.32005.11“ú–{‹@ŠBŠw‰ï@‘æ16‰ñƒoƒCƒIƒtƒƒ“ƒeƒBƒAu‰‰‰ï ŽÀsˆÏˆõ‰ïE‘gDˆÏˆõ‰ïˆÏˆõ
20032004.3The First Asian Pacific Conference on Biomechanics Local Committee Member
2002.42007.3“ú–{ƒGƒ€EƒC[Šw‰ïiŒ»F“ú–{¶‘̈ãHŠw‰ïjê–å•ÊŒ¤‹†‰ï ƒoƒCƒIƒƒJƒjƒNƒXŒ¤‹†‰ï Š²Ž–
1996.1-“ú–{ƒoƒCƒIƒŒƒIƒƒW[Šw‰ï‰ïˆõ
1995.12-“ú–{ƒGƒ€EƒC[Šw‰ïiŒ»F“ú–{¶‘̈ãHŠw‰ïj‰ïˆõ
1994.11-“ú–{‹@ŠBŠw‰ï‰ïˆõ
1990.6-“ú–{ƒoƒCƒIƒ}ƒeƒŠƒAƒ‹Šw‰ï‰ïˆõ
1990.4-“ú–{lH‘ŸŠíŠw‰ï‰ïˆõ
Žå‚ȎЉ“®
A”C“ú‘Þ”C“ú‹@ŠÖ–¼E–ðE–¼
2007.11‹ß‹EŒoÏŽY‹Æ‹Ç@’nˆæV‹KŽ–‹Æ@ÅI•]‰¿ƒsƒAƒŒƒrƒ…[ƒA
2008.11‹ß‹EŒoÏŽY‹Æ‹Ç@’nˆæV‹KŽ–‹Æ@ÅI•]‰¿ƒsƒAƒŒƒrƒ…[ƒA
ŽóÜEŠwpÜ‚È‚Ç
”NŒŽŠT—v
1992.6World Apheresis Association, Young Investigatorfs Award
1999.4“ú–{ƒGƒ€EƒC[Šw‰ïC@‰ÈŠwV•·ÜEŒ¤‹†§—ãÜ
2010.9“ú–{¶‘̈ãHŠw‰ï@¶‘̈ãHŠwƒVƒ“ƒ|ƒWƒEƒ€ƒxƒXƒgƒŠƒT[ƒ`ƒAƒ[ƒh
“Á‹–“™
”NŒŽŠT—v
-
ã‹LˆÈŠO‚Ì“Á‹LŽ–€
”NŒŽŠT—v
2004‘åã‘åŠwƒiƒmƒTƒCƒGƒ“ƒXEƒiƒmƒeƒNƒmƒƒW[‚“xŠwÛ‹³ˆçŒ¤‹†ŒP—ûƒvƒƒOƒ‰ƒ€ ’´•ªŽqƒiƒmƒoƒCƒIƒvƒƒZƒXŠwƒvƒƒOƒ‰ƒ€ ¶‘̍HŠwƒR[ƒXŽÀK@uŽti2011‚܂Łj
2005‘åã‘åŠw—Տ°ˆãHŠw—Z‡Œ¤‹†‹³ˆçƒZƒ“ƒ^[@ŽÐ‰ïlÄ‹³ˆçƒ†ƒjƒbƒg@ƒoƒCƒIƒ}ƒeƒŠƒAƒ‹ƒR[ƒXu¶‘Ì“î‘gD‚Ì—ÍŠwŠT˜_v uŽt
2006‘åã‘åŠw —Տ°ˆãHŠwEî•ñŠwƒXƒLƒ‹ƒAƒbƒvuÀ@‚“xf’fŽ¡—ÃR[ƒX@f’fŽ¡—ÃVƒXƒeƒ€Šwu¶‘Ì“î‘gD‚Ì—ÍŠwŠT˜_v@uŽt
2009‘åã‘åŠwƒiƒm—HŠwlÞˆç¬ŽYŠwƒRƒ“ƒ\[ƒVƒAƒ€@‘æ‚R‰ñƒiƒm—HŠwî•ñŒð—¬‰ïu×–E‚Ì‘€ì‚ÆŒv‘ª‚̍őOüv@uŽt
ˆêŒ¾
ŒÂlƒz[ƒ€ƒy[ƒW

[TOP‚É–ß‚é]

ŽR할  NËiYasunori Yamasakij

XV“ú2010.5.13
Ž–¼
iŠ¿ŽšjŽR할  NË
iƒJƒijƒ„ƒ}ƒTƒL   ƒ„ƒXƒmƒŠ
iRomanjYasunori   Yamasaki
Š‘®—•–ì‘åŠwˆã—Õی’Šw•”   —Տ°HŠw‰È
E–¼y‹³Žö
˜A—æZŠi567-0012j   ‘åã•{ˆï–ØŽs“Œ‘¾“c4-5-4
Tel072-627-1711   i“àü”ԍ†F94-228j
FAX072-627-1753
Mail
Šw—ð
”NŒŽ‘åŠwEŠw•”EŠw‰ÈE‘åŠw‰@EêU–¼
2009.4‘åã‘åŠw‘åŠw‰@ˆãŠwŒnŒ¤‹†‰ÈŠO‰ÈŒn—Տ°ˆãŠwêU¶‘Ì‹@”\’²ßˆãŠw   ”ŽŽm‰Û’ö   “üŠw
2007.3•ºŒÉŒ§—§‘åŠw‰ž—pî•ñ‰ÈŠwŒ¤‹†‰È   CŽm‰Û’ö   C—¹
E—ð
A”C“ú‘Þ”C“ú‹@ŠÖ–¼EE–¼E–ðE–¼
2010.4—•–ì‘åŠwˆã—Õی’Šw•”—Տ°HŠw‰È   y‹³Žö   Œ“   —Տ°HŠw‰È’·•â²
2009.22010.3—•–ì‘åŠwˆã—Õی’Šw•”—Տ°HŠw‰ÈÝ’u€”õŽº   y‹³Žö   iŠÅŒìŠw‰ÈŒ“”Cj
2008.92009.1—•–ì‘åŠwˆã—Õی’Šw•”—Տ°HŠw‰ÈÝ’u€”õŽº   “Á”CuŽt
2008.5‘åã•{—§¬l•aƒZƒ“ƒ^[zŠÂŠíf—Õ”–å   —Տ°HŠw‹ZŽmi”ñí‹ÎE—Տ°Žw“±ˆõj
2008.5‘åã“d‹C’ʐM‘åŠwˆã—ÕŸŽƒHŠw•”   ”ñí‹ÎuŽt
2008.5‘åã‘åŠwˆãŠw•”•‘®•a‰@   ‚“x‹~–½‹~‹}ƒZƒ“ƒ^[   —Տ°Œ¤‹†ˆõ
2001.92008.4‘—§zŠÂŠí•aƒZƒ“ƒ^[   Žèp•”   —Տ°HŠw‹ZŽm
1999.42001.8‘—§zŠÂŠí•aƒZƒ“ƒ^[   Žèp•”   —Տ°HŠw‹ZŽmi”ñí‹Îj
Žæ“¾ŠwˆÊCŽmi‰ž—pî•ñ‰ÈŠwjy•ºŒÉŒ§—§‘åŠwz
Ž‘ŠiE–Æ‹–
”NŒŽŠT—v
1999.5—Տ°HŠw‹ZŽm–Æ‹–i‘æ13001†j   Žæ“¾
1998.11‘æIIŽí‚l‚d‹ZpŽÀ—ÍŒŸ’莎Œ±   Žæ“¾
1997.5ŠÅŒìŽt–Æ‹–i‘æ17855†j   Žæ“¾
’S“–‰È–Ú
1”N2”N3”N4”N
—Տ°HŠwŠT˜_
‹~‹}‹~–½ˆãŠw
lH‘ŸŠíŠw
lHS”xŠwI, II
¶–½ˆÛŽ‘•’uŠwŽÀK
—Տ°ŽÀKI-IV
—Տ°HŠw‘‡‰‰K
‘²‹ÆŒ¤‹†
ƒVƒ“ƒƒfƒBƒJƒ‹Šw
ê–啪–ì—Տ°HŠwClH‘ŸŠíŠwClHS”xŠw
Š‘®Šw‰ï“ú–{lH‘ŸŠíŠw‰ïC“ú–{‘ÌŠOzŠÂ‹ZpˆãŠw‰ïC“ú–{ˆãHŠwŽ¡—Êw‰ï
Œ¤‹†ƒe[ƒ}–ŒŒ^lH”x—ò‰»ƒƒJƒjƒYƒ€‚̉𖾁ClHS”xƒI[ƒgƒpƒCƒƒbƒgƒVƒXƒeƒ€‚ÌŠJ”­C‘ÙŽ™E”D•w‚É‚¨‚¯‚élHS”xƒVƒXƒeƒ€‚ÌŠm—§
‹ÆÑ
Ží•Ê‘è–ÚŒfÚŽ–¼C‹@ŠÖ–¼“™”­s”NŒŽ
“ÁW–¢—ˆ‚̗Տ°HŠw‹ZŽm‘œPerfusion saloon2011
“ÁWƒVƒ‡ƒbƒN‚ÌŒ´ˆö‚Æ•ª—ށuŒŒ‰tˆÙí«ƒVƒ‡ƒbƒNvEMERGENCY CARECNo. 4, pp. 51-62011
˜_•¶‘Ì“àAž‚ÝŒ^¶Žº•â•lHS‘ŸiNovacor-LVASj‘•’…Š³ŽÒ‚É‚¨‚¯‚éÝ‘îŠÇ—-lHS‘ŸŠO—ˆ‚ÌŠJÝ-ˆãHŠwŽ¡—ÁCVol. 24CNo. 122008
˜_•¶Œã“V«SŽ¾Š³‚Ì–³—AŒŒÇ—á‚É‚¨‚¯‚éA-A MUF‚ÌŒŸ“¢‘ÌŠOzŠÂ‹Zp2007
˜_•¶ŒŒ‰t‰“Sƒ|ƒ“ƒv‚Ì‹ì“®‰¹‚ÉŠÖ‚·‚éŠî‘b“IŒŸ“¢‘ÌŠOzŠÂ‹Zp2007
˜_•¶‘Ì“àAž‚ÝŒ^¶Žº•â•lHS‘Ÿ‚É‚¨‚¯‚éˆÙí‚Ì‘Šú”­Œ©‚Ì‚½‚ß‚Ì‹ì“®‰¹‰ðÍ‚ÉŠÖ‚·‚錤‹†CŽm˜_•¶C•ºŒÉŒ§—§‘åŠw2007
˜_•¶‰“ˆÊ‹|•”‘å“®–¬áŽŽèp‚ɑ΂·‚é‘ÌŠOzŠÂ‚̐V‚½‚È‚éí—ª‘ÌŠOzŠÂ‹Zp2007
˜_•¶ƒwƒpƒŠƒ“‹Nˆö«ŒŒ¬”ÂŒ¸­ÇIIŒ^Š³ŽÒ‚ɑ΂µ‚ĐlHS”x‚ðŽ{s‚µ‚½4—á‘ÌŠOzŠÂ‹Zp2007
˜_•¶—Տ°HŠw‹ZŽm—{¬‰Û’ö‚ÌŠw¶‚É‚¨‚¯‚éŽèpŽºilHS”xjŽÀK‚ÌŒ»ó‘ÌŠOzŠÂ‹Zp2007
˜_•¶¬Ž™•â•zŠÂ‰ñ˜H‚É‚¨‚¯‚錌‰t[“U‚̍H•v[¬Ž™—pƒGƒ}ƒZƒu‚ɂ‚¢‚ā[‘ÌŠOzŠÂ‹Zp2007
˜_•¶ –³—AŒŒ‚ð’B¬‚µ‚½æ“V«SŽ¾Š³ŠJSp‚É‚¨‚¯‚éMUF‚ÌŒŸ“¢‘ÌŠOzŠÂ‹Zp2007
˜_•¶Early Experience with Low-Prime (99mL) Extracorporeal Membrane Oxygenation Support in ChildrenASAIO journal2005
Šw‰ïŠˆ“®
A”C“ú‘Þ”C“ú‹@ŠÖ–¼E–ðE–¼
2009-“ú–{¬Ž™ECLSŒ¤‹†‰ï@Ž––±‹Ç’·
ŽÐ‰ï“IŠˆ“®
A”C“ú‘Þ”C“ú‹@ŠÖ–¼E–ðE–¼
2012-ˆê”ÊŽÐ’c–@l@‘åã•{—Տ°HŠw‹ZŽm‰ï@—Ž–iŠwpE‹³ˆç’S“–j
2012-ˆê”ÊŽÐ’c–@l@“ú–{—Տ°HŠw‹ZŽm‹³ˆçŽ{Ý‹¦‹c‰ï@—Ž–
2013-“ú–{—Տ°HŠw‹ZŽm˜A–¿@—Ž–i‹ß‹EƒuƒƒbƒN’S“–j
2013-ŠwZ–@l•rˆäŠw‰€@“ú–{ƒƒfƒBƒJƒ‹•ŸŽƒê–åŠwZ@ŠwZŠÖŒWŽÒ•]‰¿ˆÏˆõ
2013-ŠwZ–@l•rˆäŠw‰€@“ú–{ƒƒfƒBƒJƒ‹•ŸŽƒê–åŠwZ@E‹ÆŽÀ‘Hê–å‰Û’ö•Ò¬ˆÏˆõ
“Á‹–“™
”NŒŽŠT—v
-
ˆêŒ¾Ž©‚çi‚ñ‚Å‹t‹«‚É“¥‚ݍž‚à‚¤I   ‚»‚ꂪŽ©g‚𐬒·‚³‚¹l¶‚Ì—Æ‚Æ‚È‚éB
ŒÂlƒz[ƒ€ƒy[ƒW

[TOP‚É–ß‚é]

‹e’r   “µiHitomi Kikuchij

XV“ú2015.6.1
Ž–¼
iŠ¿Žšj‹e’r   “µ
iƒJƒijƒLƒNƒ`   ƒqƒgƒ~
iRomanjHitomi   Kikuchi
Š‘®—•–ì‘åŠwˆã—Õی’Šw•”   —Տ°HŠw‰È
E–¼uŽt
˜A—æZŠi567-0012j   ‘åã•{ˆï–ØŽs“Œ‘¾“c4-5-4
Tel072-627-1711   i“àü”ԍ†F94-227j
FAX072-627-1753
Mail
Šw—ð
”NŒŽ‘åŠwEŠw•”EŠw‰ÈE‘åŠw‰@EêU–¼
2015.3•ºŒÉŒ§—§‘åŠw‰ž—pî•ñ‰ÈŠwŒ¤‹†‰È   ”ŽŽmŒãŠú‰Û’ö   ‰ž—pî•ñŠwˆÊŽæ“¾
2013.9•ºŒÉŒ§—§‘åŠw‰ž—pî•ñ‰ÈŠwŒ¤‹†‰È   ”ŽŽmŒãŠú‰Û’ö   ’PˆÊŽæ“¾‘ÞŠw
2010.10•ºŒÉŒ§—§‘åŠw‰ž—pî•ñ‰ÈŠwŒ¤‹†‰È   ”ŽŽmŒãŠú‰Û’ö   “üŠw
2010.3•ºŒÉŒ§—§‘åŠw‰ž—pî•ñ‰ÈŠwŒ¤‹†‰È   ”ŽŽm‘OŠú‰Û’ö   C—¹
2008.4•ºŒÉŒ§—§‘åŠw‰ž—pî•ñ‰ÈŠwŒ¤‹†‰È   ”ŽŽm‘OŠú‰Û’ö   “üŠw
E—ð
A”C“ú‘Þ”C“ú‹@ŠÖ–¼EE–¼E–ðE–¼
2010.4—•–ì‘åŠwˆã—Õی’Šw•”—Տ°HŠw‰È   uŽt
2001.42009.3‘åãˆãê—Տ°HŠw‰È   ê”CuŽt
1992.42001.1ˆã—Ö@l–¾¶‰ï–¾¶•a‰@
Žæ“¾ŠwˆÊ”ŽŽmi‰ž—pî•ñŠwjy•ºŒÉŒ§—§‘åŠwz
Ž‘ŠiE–Æ‹–
”NŒŽŠT—v
1992.6—Տ°HŠw‹ZŽm–Æ‹–i‘æ7512†j@Žæ“¾
’S“–‰È–Ú
1”N2”N3”N4”N
-
¶—ŠwŽÀK
¶‘ÌŒv‘ª‹@ŠíŠw
¶‘ÌŒv‘ª‹@ŠíŠwŽÀK
ƒVƒ“ƒƒfƒBƒJƒ‹˜_
—Տ°ŽÀK
—Տ°HŠw‘‡‰‰K
‘²‹ÆŒ¤‹†
ê–啪–ì‘ÙŽ™EV¶Ž™ˆãŠw
Š‘®Šw‰ï“ú–{—Տ°HŠw‹ZŽm‰ïC“ú–{ŽY‰È•wl‰ÈŠw‰ïC“ú–{ŽüŽYŠúEV¶Ž™ˆãŠw‰ï
Œ¤‹†ƒe[ƒ}‘ÙŽ™S”w’ɐ}‚Æ‘ÙŽ™ƒAƒXƒtƒBƒLƒVƒA
‹ÆÑ
Ží•Ê‘è–ÚŒfÚŽ–¼C‹@ŠÖ–¼“™”­s”NŒŽ
Šwp˜_•¶•ª•Ø’†‚̈ê‰ß«™–¬‚̃pƒ^[ƒ“‚Æ•ª•Ø’¼Œã‚Ìä`‘Ñ“®–¬ŒŒ•ªÍ’l‚ÉŠÖ‚·‚錟“¢“ú–{ŽüŽYŠúEV¶Ž™ˆãŠw‰ïŽGŽ51 (1)C180-1852015.5
’˜‘‘ÙŽ™S””w’ɐ}‚̃pƒ^[ƒ“•ª—Þ‚Æ‚»‚Ì—LŒø«‚ÉŠÖ‚·‚錤‹†”ŽŽm˜_•¶C•ºŒÉŒ§—§‘åŠw2015.3
Šwp˜_•¶Mechanism of Reduction of Newborn Metabolic Acidemia following Application of a Rule-based 5-Category Colour Coded Fetal Heart Rate Management FrameworkJ Maternal-Fetal & Neonatal Med, Early Online: 1-62014.9
Šwp˜_•¶ŒŒ‰t“§Í‚É‚¨‚¯‚éúŽhj‚ƃ‹ƒA[ƒRƒlƒNƒ^‚̐ڑ±—͂ɂ‚¢‚Ä‚ÌŒ¤‹†‘åã“§ÍŒ¤‹†‰ï‰ïŽC32i2jpp.127-1312014.8
Šwp˜_•¶•ª•Ø’†‚Ì‘ÙŽ™S”””gŒ`‚̃Œƒxƒ‹•ª—Þ‚Æ•ª•Ø’¼Œã‚Ìä`‘Ñ“®–¬ŒŒƒKƒX•ªÍ’l‚Æ‚ÌŠÖ˜A«“ú–{ŽüŽYŠúEV¶Ž™ˆãŠw‰ïŽ, 49 (4), pp.1240-12462013.12
‘Û‰ï‹cPanel Data Analysis of Cardiotocograph (CTG) DataProceedings of the 14th World Congress on Medical and Health Informatics MEDINFO 20132013.8
Šwp˜_•¶—Տ°ŽÀK‚É‚¨‚¯‚éŠw¶‚Ì–ž‘«“x‚Æ‹C•ªó‘Ô‚¨‚æ‚ÑŽ©ŒÈ•]‰¿‚Æ‚ÌŠÖ˜A«“ú–{—Տ°HŠw‹ZŽm‰ï‰ïŽC47Cpp.54|592013.4
ƒ|ƒXƒ^[”­•\ƒpƒlƒ‹ƒf[ƒ^•ªÍ‚ÌCTGƒf[ƒ^‰ðÍ‚ւ̉ž—p‘æ32‰ñˆã—Ïî•ñŠw˜A‡‘å‰ï2012.11
ƒ|ƒXƒ^[”­•\ŽY‰Èê–åˆã‚É‚æ‚é‘ÙŽ™S””w’ɐ}”»“ǂ̈ê’v“x‚ÌŒŸ“¢`“¯ˆêŽ{Ý‚Æ‘¼Ž{Ý‚Ì”äŠr`‘æ16‰ñ“ú–{ˆã—Ïî•ñŠw‰ït‹GŠwp‘å‰ï2012.6
‘Û‰ï‹cRelationship between 5-tier color-coded framework of fetal heart rate pattern and umbilical arterial blood gas31st Annual Meeting, Society for Maternal-Fetal Medicine2011.2
“Á‹–“™
”NŒŽŠT—v
-
ˆêŒ¾—Տ°HŠw‹ZŽm‚ð–ÚŽw‚µ‚Ĉꏏ‚ÉŠæ’£‚è‚Ü‚µ‚傤I
ŒÂlƒz[ƒ€ƒy[ƒW

[TOP‚É–ß‚é]

ŒS   T•½iKohri Shimpeij

XV“ú2015.6.18
Ž–¼
iŠ¿ŽšjŒS   T•½
iƒJƒijƒRƒIƒŠ   ƒVƒ“ƒyƒC
iRomanjShimpei   Kohri
Š‘®—•–ì‘åŠwˆã—Õی’Šw•”   —Տ°HŠw‰È
E–¼uŽt
˜A—æZŠi567-0012j   ‘åã•{ˆï–ØŽs“Œ‘¾“c4-5-4
Tel072-627-1711   i“àü”ԍ†F94-224j
FAX072-627-1753
Mail
Šw—ð
”NŒŽ‘åŠwEŠw•”EŠw‰ÈE‘åŠw‰@EêU–¼
2008.3ŠÖ¼‘åŠw‘åŠw‰@HŠwŒ¤‹†‰È   ”ŽŽm‰Û’öŒãŠú‰Û’ö‹@ŠBHŠwêU   C—¹
2005.4ŠÖ¼‘åŠw‘åŠw‰@HŠwŒ¤‹†‰È   ”ŽŽm‰Û’öŒãŠú‰Û’ö‹@ŠBHŠwêU   “üŠw
E—ð
A”C“ú‘Þ”C“ú‹@ŠÖ–¼EE–¼E–ðE–¼
2010.4—•–ì‘åŠwˆã—Õی’Šw•”—Տ°HŠw‰È   uŽt
2008.4ŠÖ¼‘åŠwæ’[‰ÈŠw‹Zp„i‹@\   ƒ|ƒXƒgƒhƒNƒgƒ‰ƒ‹ƒtƒFƒ[
Žæ“¾ŠwˆÊ”ŽŽmiHŠwjyŠÖ¼‘åŠwz
Ž‘ŠiE–Æ‹–
”NŒŽŠT—v
2009.3Œõƒtƒ@ƒCƒo[ƒRƒlƒNƒ^CF-2071‰ÁH@Ž‘ŠiŽæ“¾
2008.3”ŽŽmiHŠwj@HŠw‘æ96†
2007.3—Տ°ˆãHŠwEî•ñ‰ÈŠw‹ZpŽÒÄ‹³ˆçƒ†ƒjƒbƒg‹³ˆçƒvƒƒOƒ‰ƒ€i‹¤’ʁC‚“xf’fŽ¡—ÍHŠwƒR[ƒXj@C—¹
2003.1—Տ°ˆãHŠwEî•ñ‰ÈŠw‹ZpŽÒÄ‹³ˆçƒ†ƒjƒbƒg‹³ˆçƒvƒƒOƒ‰ƒ€i‚“xf’fŽ¡—ÍHŠwƒR[ƒXj@C—¹
’S“–‰È–Ú
1”N2”N3”N4”N
”ŠwŠî‘bICII
”ŠwŠî‘b‰‰KICII
‹@ŠBHŠw
‹@ŠBHŠw‰‰K
‹@ŠBHŠwŽÀK
‘²‹ÆŒ¤‹†
—Տ°HŠw‘‡‰‰K
ê–啪–ì‹@ŠBHŠwClŠÔˆãHŠw
Š‘®Šw‰ï“ú–{‹@ŠBŠw‰ï
Œ¤‹†ƒe[ƒ}¶‘Ì“àŒŒ—¬Œv‘ª‚ÌŽè–@E‹@Ší‚ÌŠJ”­CÔŒŒ‹…‚Ì—ÍŠw“I•¨«•]‰¿
‹ÆÑ
Ží•Ê‘è–ÚŒfÚŽ–¼C‹@ŠÖ–¼“™”­s”NŒŽ
˜_•¶
i¸“Ç‚ ‚èj
’PŽ²ˆø’£‚É‚æ‚éƒqƒgÔŒŒ‹…‚Ì•ÏŒ`”\‚Ì‘ª’è-Œ©‚©‚¯‚̃„ƒ“ƒO—¦‚ÆŒ`ó‰ñ•œŽž’萔‚ÌŠÖŒW-¶‘̈ãHŠwCVol. 53 (1)Cpp. 1-72015
˜_•¶
i¸“Ç‚ ‚èj
”\“®“I’´‰¹”gƒhƒbƒvƒ‰[–@‚É‚æ‚錌—¬’†‚̐ðŽq‚Æ‹C–A‚ÌŽ¯•Ê•û–@‚ÌŠJ”­2iƒqƒg’†‘å”]“®–¬”“®ŒŒ—¬‚ð‘ΏۂƂµ‚½¶‘ÌŠO–Í‹[ŽÀŒ±j¶‘̈ãHŠw, Vol. 51, No. 6, pp. 397-4042013
˜_•¶
i¸“Ç‚ ‚èj
Development of Miniaturized Fiber-Optic Laser Doppler Velocimetry Sensor for Measuring Local Blood Velocity: Measurement of Whole Blood Velocity in Model Blood Vessel Using a Fiber-Optic Sensor with a Convex Lens-Like TipJournal of Sensors, DOI: 10.1155/2012/4264762012
˜_•¶
i¸“Ç‚ ‚èj
Development of a Miniaturized Fiber-optic LDV Sensor for Local Blood Velocity MeasurementBiomedical Engineering Research, Vol. 2, No. 3, pp. 131-1382010
˜_•¶
i¸“Ç‚ ‚èj
ƒ}ƒCƒNƒƒ`ƒƒƒ“ƒlƒ‹‚ð’ʉ߂·‚éÔŒŒ‹…‚Ì•ÏŒ`‹““®‚Æ“à•”—¬“®‚Ì“ñŽŸŒ³”’lƒVƒ~ƒ…ƒŒ[ƒVƒ‡ƒ“‚É‚æ‚éŠÏŽ@“ú–{‹@ŠBŠw‰ï˜_•¶W(B•Î), 76Šª772†, pp. 117-1232009
˜_•¶
i¸“Ç‚ ‚èj
”\“®“I’´‰¹”gƒhƒbƒvƒ‰[–@‚É‚æ‚錌—¬’†‚̐ðŽq‚Æ‹C–A‚ÌŽ¯•Ê•û–@‚ÌŠJ”­D1i…—¬‚¨‚æ‚Ñ–Í‹[ŒŒ—¬’†‚Å’´‰¹”g‚ðŠÇŽ²‚Ɛ‚’¼‚ɏƎ˂·‚éŽÀŒ±j¶‘̈ãHŠwCVol. 47, No. 1Cpp. 28-352009
˜_•¶
i¸“Ç‚ ‚èj
‹ÇŠŒŒ—¬‘¬‘ª’è—pŒõƒtƒ@ƒCƒo[LDVƒZƒ“ƒT[‚ÌŠJ”­”ŽŽm˜_•¶CŠÖ¼‘åŠw2008
˜_•¶
i¸“Ç‚ ‚èj
Development of Miniaturized Fiber-Optic Laser Doppler Velocimetry Sensor for Measurement of Local Blood Velocity (Fabrication Method for Convex or Concave Lens-Like Fiber Tip and the Characteristics of Sensor Optical System) Journal of Fluid Scie-nce and Technology, Vol. 4, No. 1, pp. 62-742007
˜_•¶
i¸“Ç‚ ‚èj
‹ÇŠŒŒ—¬‘¬‘ª’è—pŒõƒtƒ@ƒCƒo[LDVƒZƒ“ƒT[‚ÌŠJ”­ -–Í‹[ŒŒŠÇ“à”“®ŒŒ—¬‚ÌŠÇ’f–Ê“à—¬‘¬•ª•z‚Ì‘ª’è-¶‘̈ãHŠw, Vol. 45, No. 4, pp. 298-3062006
˜_•¶
i¸“Ç‚ ‚èj
‹ÇŠŒŒ—¬‘¬‘ª’è—pŒõƒtƒ@ƒCƒo[LDVƒZƒ“ƒT[‚ÌŠJ”­iŒõƒtƒ@ƒCƒo[ƒZƒ“ƒT[‚É‚æ‚é–Í‹[ŒŒŠÇ“à‚̃qƒgŒŒ‰t‚Ì—¬‘¬‘ª’èj“ú–{‹@ŠBŠw‰ï˜_•¶WiB•Îj, 72Šª719†, pp. 1702-17092006
“Á‹–“™
”NŒŽŠT—v
-
ˆêŒ¾wŽv‚¢—§‚Á‚½‚ç‹g“úi‚»‚êˆÈŠO‚Í‹¥“úHjx‚Å‚·B
ŒÂlƒz[ƒ€ƒy[ƒW

[TOP‚É–ß‚é]

V“c   ‰À”ŒiYoshinori Nittaj

XV“ú2010.5.10
Ž–¼
iŠ¿ŽšjV“c   ‰À”Œ
iƒJƒijƒjƒbƒ^   ƒˆƒVƒmƒŠ
iRomanjYoshinori   Nitta
Š‘®—•–ì‘åŠwˆã—Õی’Šw•”   —Տ°HŠw‰È
E–¼uŽt
˜A—æZŠi567-0012j   ‘åã•{ˆï–ØŽs“Œ‘¾“c4-5-4
Tel072-627-1711   i“àü”ԍ†F94-225j
FAX072-627-1753
Mail
Šw—ð
”NŒŽ‘åŠwEŠw•”EŠw‰ÈE‘åŠw‰@EêU–¼
2005.4“¿“‡‘åŠw‘åŠw‰@HŠwŒ¤‹†‰È   ”ŽŽmŒãŠú‰Û’ö   “üŠw
2005.3“¿“‡‘åŠw‘åŠw‰@HŠwŒ¤‹†‰È   ”ŽŽm‘OŠú‰Û’ö   C—¹
E—ð
A”C“ú‘Þ”C“ú‹@ŠÖ–¼EE–¼E–ðE–¼
2010.4—•–ì‘åŠwˆã—Õی’Šw•”—Տ°HŠw‰È   uŽt
Žæ“¾ŠwˆÊCŽmy“¿“‡‘åŠwz
Ž‘ŠiE–Æ‹–
”NŒŽŠT—v
-
’S“–‰È–Ú
1”N2”N3”N4”N
“d‹CHŠwI
î•ñ‰ÈŠwŽÀK
“d‹CHŠwŽÀK
ƒVƒXƒeƒ€§ŒäHŠw
ƒVƒXƒeƒ€§ŒäHŠwŽÀK
“dŽqHŠwŽÀKI, II
—Տ°HŠw‘‡‰‰K
‘²‹ÆŒ¤‹†
ê–啪–ìˆã—p¶‘̍HŠw
Š‘®Šw‰ï“ú–{¶‘̈ãHŠw‰ïC“dŽqî•ñ’ʐMŠw‰ïCˆã—Â̎¿EˆÀ‘SŠw‰ï
Œ¤‹†ƒe[ƒ}ŒŒ‰tò‰»—Ö@‚̈À‘S«Œüã‚ÉŠÖ‚·‚錤‹†
‹ÆÑ
Ží•Ê‘è–ÚŒfÚŽ–¼C‹@ŠÖ–¼“™”­s”NŒŽ
˜_•¶Influence of Leukocytapheresis Therapy for Ulcerative Colitis on Anemia and HemodynamicsTherapeutic Apheresis and Dialysis2007
“Á‹–“™
”NŒŽŠT—v
-
ˆêŒ¾“d‹C‚ªD‚«‚ȗՏ°HŠwŽm‚ð–ÚŽw‚µ‚Ä‹¤‚É‚ª‚ñ‚΂è‚Ü‚µ‚傤B
ŒÂlƒz[ƒ€ƒy[ƒW

[TOP‚É–ß‚é]

—Ñ   ‘ñ¢iTakuto Hayashij

XV“ú2013.10.19
Ž–¼
iŠ¿Žšj—Ñ   ‘ñ¢
iƒJƒijƒnƒ„ƒV   ƒ^ƒNƒg
iRomanjTakuto   Hayashi
Š‘®—•–ì‘åŠwˆã—Õی’Šw•”   —Տ°HŠw‰È
E–¼uŽt
˜A—æZŠi567-0012j   ‘åã•{ˆï–ØŽs“Œ‘¾“c4-5-4
Tel072-627-1711   i“àü”ԍ†F94-232j
FAX072-627-1753
Mail
Šw—ð
”NŒŽ‘åŠwEŠw•”EŠw‰ÈE‘åŠw‰@EêU–¼
2010.3•ºŒÉŒ§—§‘åŠw‰ž—pî•ñ‰ÈŠwŒ¤‹†‰È   ”ŽŽmŒãŠú‰Û’ö   C—¹
2007.4•ºŒÉŒ§—§‘åŠw‰ž—pî•ñ‰ÈŠwŒ¤‹†‰È   ”ŽŽmŒãŠú‰Û’ö   “üŠw
E—ð
A”C“ú‘Þ”C“ú‹@ŠÖ–¼EE–¼E–ðE–¼
2010.4—•–ì‘åŠwˆã—Õی’Šw•”—Տ°HŠw‰È   uŽt
Œ¤‹†—ð
A”C“ú‘Þ”C“ú‹@ŠÖ–¼EE–¼E–ðE–¼
2013.8•ºŒÉŒ§—§‘åŠw‘åŠw‰@‰ž—pî•ñ‰ÈŠwŒ¤‹†‰È   ŽÐ‰ï‰ž—pî•ñ‰ÈŠwŒ¤‹†ƒZƒ“ƒ^[   Œ¤‹†ƒvƒƒWƒFƒNƒgŒ¤‹†ˆõ
Žæ“¾ŠwˆÊ”ŽŽmi‰ž—pî•ñ‰ÈŠwjy•ºŒÉŒ§—§‘åŠwz
Ž‘ŠiE–Æ‹–
”NŒŽŠT—v
2005.5—Տ°HŠw‹ZŽm–Æ‹–i‘æ19956†j   Žæ“¾
200x.x‘æ2ŽíME‹ZpŽÀ—ÍŒŸ’莎Œ±   Žæ“¾
’S“–‰È–Ú
1”N2”N3”N4”N
ƒVƒ“ƒƒfƒBƒJƒ‹I
î•ñ‰ÈŠwŽÀK
ˆã—pŽ¡—Ë@ŠíŠwŽÀK
ˆã—p‹@ŠíˆÀ‘SŠÇ—ŠwI, II
ˆã—p‹@ŠíˆÀ‘SŠÇ—ŠwŽÀK
—Տ°ŽÀKI-IV
—Տ°HŠw‘‡‰‰K
‘²‹ÆŒ¤‹†
ê–啪–쐶‘̈ãHŠwC—Տ°_Œo¶—Šw
Š‘®Šw‰ï
Œ¤‹†ƒe[ƒ}ƒXƒgƒŒƒXó‘Ô‚É‚¨‚¯‚鐶—Šw“I‹@”\‰ðÍ
‹ÆÑ
Ží•Ê‘è–ÚŒfÚŽ–¼C‹@ŠÖ–¼“™”­s”NŒŽ
˜_•¶EEG activities evoked by trauma stimuli related to earthquakes and personality features associated with traumaIC-MED Journal2011
˜_•¶‘½Œ³“I¶—ŠwM†‰ðÍ‚É‚æ‚é“ÁˆÙ“IƒXƒgƒŒƒX”½‰ž‚Ì’è—Ê•]‰¿”ŽŽm˜_•¶C•ºŒÉŒ§—§‘åŠw2010
˜_•¶¸_ì‹Æ•‰‰×Žž‚É‚¨‚¯‚éì‹ÆŠÂ‹«‚ÆŠÖ˜A‚µ‚½”]”gE–¬”g‚Ì’è—ʉðÍ¶‘̈ãHŠw2010
˜_•¶Beta activities in EEG associated with emotional stressIC-MED Journal2009
˜_•¶ƒgƒ‰ƒEƒ}‚ð˜A‘z‚³‚¹‚éî“®ŽhŒƒ’¼Œã‚Ì”]‹@”\•Ï‰»‚Ɛ«ŠiŒXŒü‚Æ‚ÌŠÖ˜A«—Տ°”]”g2009
˜_•¶î“®ƒXƒgƒŒƒX•‰‰×‚É”º‚¤”]‹@”\‚ÌŒoŽž“I•Ï‰»“dŽqî•ñ’ʐMŠw‰ï˜_•¶ŽD2008
˜_•¶î“®‚ð”]”g‚Å‘ª’è‚·‚é—Տ°”]”g2006
“Á‹–“™
”NŒŽŠT—v
-
ˆêŒ¾wƒXƒgƒŒƒX‚͐l¶‚̃XƒpƒCƒX!!x‚炵‚¢‚Å‚·D
ŒÂlƒz[ƒ€ƒy[ƒWŒÂlƒz[ƒ€ƒy[ƒWi‰¼j

[TOP‚É–ß‚é]

”¨’†   —R‰ÀiYuka Hatanakaj

XV“ú2015.6.1
Ž–¼
iŠ¿Žšj”¨’†   —R‰À
iƒJƒijƒnƒ^ƒiƒJ   ƒ†ƒJ
iRomanjYuka   Hatanaka
Š‘®—•–ì‘åŠwˆã—Õی’Šw•”   —Տ°HŠw‰È
E–¼•‹³
˜A—æZŠi567-0012j   ‘åã•{ˆï–ØŽs“Œ‘¾“c4-5-4
Tel072-627-1711   i“àü”ԍ†F94-226j
FAX
Mail
Šw—ð
”NŒŽ‘åŠwEŠw•”EŠw‰ÈE‘åŠw‰@EêU–¼
2013.3ŽOd‘åŠw‘åŠw‰@   ˆãŠwŒnŒ¤‹†‰È   ˆã‰ÈŠwêU   CŽm‰Û’ö   C—¹
2011.4ŽOd‘åŠw‘åŠw‰@   ˆãŠwŒnŒ¤‹†‰È   ˆã‰ÈŠwêU   CŽm‰Û’ö   “üŠw
2006.3‰ªŽR—‰È‘åŠw@—Šw•”@‰ž—p•¨—Šw‰È   ˆã—p‰ÈŠwêU   ‘²‹Æ
2006.3_ŒË‘‡ˆã—ÉîŒì•ŸŽƒê–åŠwZ   —Տ°HŠwêU‰È@‘²‹Æ
E—ð
A”C“ú‘Þ”C“ú‹@ŠÖ–¼EE–¼E–ðE–¼
2011.5—•–ì‘åŠw   ˆã—Õی’Šw•”   —Տ°HŠw‰È   •‹³
2008.42011.4ˆã—Ö@l   ‘“—´‰ï   ˆäã•a‰@   —Տ°HŠw‰Û   —Տ°HŠw‹ZŽm
2007.112008.2“Á’èˆã—Ö@l   ƒm‰ï   ‰ªŽR’†‰›•a‰@   f—ËZpŽx‰‡•”   —Տ°HŠw‹ZŽm
2006.42007.10‘—§zŠÂŠí•aƒZƒ“ƒ^[   Žèp•”@—Տ°HŠw‹ZŽm
Žæ“¾ŠwˆÊCŽmiˆã‰ÈŠwjyŽOd‘åŠwz
Ž‘ŠiE–Æ‹–
”NŒŽŠT—v
2010“§Í‹Z”\‚Q‹‰ŒŸ’èi‘æ210100075†j   ‡Ši
2010“§Í‹Zp”F’èŽmi‘æ13024†j   Žæ“¾
2009—Տ°MEê–å”F’èŽmi‘æ679†j   Žæ“¾
2009‘æ‚PŽíME‹ZpŽÒi‘æ109067†j   Žæ“¾
2006—Տ°HŠw‹ZŽm–Æ‹–i‘æ20162†j   Žæ“¾
2004‘æ‚QŽíME‹ZpŽÒi‘æ2040494†j   Žæ“¾
’S“–‰È–Ú
1”N2”N3”N4”N
-
-
ƒVƒ“ƒƒfƒBƒJƒ‹˜_
ŒŒ‰tò‰»—Ö@ŠwI
ŒŒ‰tò‰»—Ö@ŠwII
¶–½ˆÛŽŠÇ—‘•’uŠwŽÀK
¶‘ÌŒv‘ª‹@ŠíŠwŽÀK
—Տ°ŽÀKI-IV
—Տ°HŠw‘‡‰‰K
‘²‹ÆŒ¤‹†
ê–啪–쌌‰tò‰»C‘ÌŠOzŠÂ
Š‘®Šw‰ï“ú–{—Տ°HŠw‹ZŽm‰ïC‘åã•{—Տ°HŠw‹ZŽm‰ïC“ú–{‘ÌŠOzŠÂ‹ZpˆãŠw‰ï
Œ¤‹†ƒe[ƒ}ŒŒ‰tò‰»‚ÉŠÖ‚·‚錤‹†C•â•zŠÂ‚ÉŠÖ‚·‚錤‹†
‹ÆÑ
Ží•Ê‘è–ÚŒfÚŽ–¼C‹@ŠÖ–¼“™”­s”NŒŽ
˜_•¶AESCULON mini®‚É‚æ‚éæ“V«SŽ¾Š³pŒã‚Ì”ñNP“IS”o—Ê•]‰¿‚Ì—L—p«CŽm˜_•¶CŽOd‘åŠw2013
Œû“ª”­•\‘ÌŠOzŠÂ‚ÌŒ»ó‚Æ’áNP‰»‚Ö‚Ì’§í@Modified UltrafiltrationiMUFj‚ÌŒø‰Ê@‚Ó‚é‚¢ŒW”‚ÌŽ‹“_‚©‚çlH‘ŸŠí2007
Œû“ª”­•\ƒwƒpƒŠƒ“‹Nˆö«ŒŒ¬”ÂŒ¸­ÇIIŒ^Š³ŽÒ‚ɑ΂µlHS”x‚ðŽ{s‚µ‚½4Ç—á‘ÌŠOzŠÂ‹Zp2007
Œû“ª”­•\ŒŒ‰t‰“Sƒ|ƒ“ƒv‚Ì‹ì“®‰¹‚ÉŠÖ‚·‚éŠî‘b“IŒŸ“¢‘ÌŠOzŠÂ‹Zp2007
Šw‰ïŠˆ“®
A”C“ú‘Þ”C“ú‹@ŠÖ–¼E–ðE–¼
2011-“ú–{¬Ž™ECLSŒ¤‹†‰ï@‰ïŒv
Žå‚ȎЉ“®“™
A”C“ú‘Þ”C“ú‹@ŠÖ–¼E–ðE–¼
2012-ˆê”ÊŽÐ’c–@l@‘åã•{—Տ°HŠw‹ZŽm‰ï@ŠwpˆÏˆõiŒ¤‹†E‹³ˆç•”–åj
“Á‹–“™
”NŒŽŠT—v
-
ˆêŒ¾
ŒÂlƒz[ƒ€ƒy[ƒW

[TOP‚É–ß‚é]

Î–ì   ’¼–¾iNaoaki Ishinoj

XV“ú2015.6.1
Ž–¼
iŠ¿ŽšjÎ–ì   ’¼–¾
iƒJƒijƒCƒVƒm   ƒiƒIƒAƒL
iRomanjNaoaki   Ishino
Š‘®—•–ì‘åŠwˆã—Õی’Šw•”   —Տ°HŠw‰È
E–¼•‹³
˜A—æZŠi567-0012j   ‘åã•{ˆï–ØŽs“Œ‘¾“c4-5-4
Tel072-627-1711   i“àü”ԍ†F94-234j
FAX
Mail
Šw—ð
”NŒŽ‘åŠwEŠw•”EŠw‰ÈE‘åŠw‰@EêU–¼
2012.3‘åãH‹Æ‘åŠw‘åŠw‰@   HŠwŒ¤‹†‰È   ¶‘̈ãHŠwêU   ”ŽŽm‘OŠú‰Û’ö   C—¹
2002.3‘åãŽY‹Æ‘åŠw   HŠw•”   “d‹C“dŽqHŠw‰È   ‘²‹Æ
E—ð
A”C“ú‘Þ”C“ú‹@ŠÖ–¼EE–¼E–ðE–¼
2013.4—•–ì‘åŠwˆã—Õی¯Šw•”   —Տ°HŠw‰È   •‹³
2010.4—•–ì‘åŠwˆã—Õی¯Šw•”   —Տ°HŠw‰È   •Žè
2010.42013.4—LàV‘‡•a‰@   ŒŒ‰tò‰»ƒZƒ“ƒ^[   —Տ°HŠw‹ZŽmi”ñí‹ÎEŒ“‹Æj
2007.42010.3‘—§zŠÂŠí•aƒZƒ“ƒ^[   Žèp•”   —Տ°HŠw‹ZŽm
Žæ“¾ŠwˆÊCŽmiHŠwjy‘åãH‹Æ‘åŠwz
Ž‘ŠiE–Æ‹–
”NŒŽŠT—v
2007.4—Տ°HŠw‹ZŽm–Æ‹–   Žæ“¾
2006.11‘æ2ŽíME‹ZpŽÀ—ÍŒŸ’莎Œ±   Žæ“¾
’S“–‰È–Ú
1”N2”N3”N4”N
•¨—ŠwŠî‘b‰‰KIEII
ƒVƒ“ƒƒfƒBƒJƒ‹ŠwIII
ˆã—pŽ¡—Ë@ŠíŠwIEII
ˆã—pŽ¡—Ë@ŠíŠwŽÀK
—Տ°ŽÀKIEIIEIIIEIV
—Տ°HŠw‘‡‰‰K
‘²‹ÆŒ¤‹†
ê–啪–ì‘gDHŠwiTissue Engineeringj, ƒoƒCƒIƒ}ƒeƒŠƒAƒ‹
Š‘®Šw‰ï“ú–{Ä¶ˆã—Êw‰ïC“ú–{¶‘̈ãHŠw‰ïC“ú–{“®•¨ŽÀŒ±‘ã‘Ö–@Šw‰ïCƒ‰ƒCƒtƒTƒ|[ƒgŠw‰ïC“ú–{lH‘ŸŠíŠw‰ï
Œ¤‹†ƒe[ƒ}Ä¶Œ^‘gDˆÚA‚ÉŠÖ‚·‚錤‹†
‹ÆÑ
Ží•Ê‘è–ÚŒfÚŽ–¼C‹@ŠÖ–¼“™”­s”NŒŽ
Œû“ª”­•\ŒŒ´‚ð—p‚¢‚½’E×–Eˆ—ðŒ‚ÌŒŸ“¢‚Ɛ¶‘Ì“K‡«•]‰¿‘æ14‰ñ“ú–{Ä¶ˆã—Êw‰ï‘‰ï2015.3
Šwp˜_•¶i¸“Ç—LjDecellularization of porcine carotid by the recipient's serum and evaluation of its biocompatibility using a rat autograft modelJournal of Artificial Organs DOI 10.1007/s10047-015-0819-z2015.1
ƒ|ƒXƒ^[”­•\ATP‘ª’è–@‚ð—p‚¢‚½¶‘̍ޗ¿‚Ìin vitroRŒŒð«•]‰¿“ú–{“®•¨ŽÀŒ±‘ã‘Ö–@Šw‰ï‘æ27‰ñ‘å‰ï2014.12
ƒ|ƒXƒ^[”­•\ƒ‹ƒVƒtƒFƒŠƒ“-ƒ‹ƒVƒtƒFƒ‰[ƒ[”½‰ž‚É‚æ‚é”­ŒõŒ»Û‚ð—˜—p‚µ‚½¶‘̍ޗ¿‚̍RŒŒð«•]‰¿¶‘̈ãHŠwƒVƒ“ƒ|ƒWƒEƒ€20142014.9
“Á‹–“™
”NŒŽŠT—v
-
ˆêŒ¾
ŒÂlƒz[ƒ€ƒy[ƒW

[TOP‚É–ß‚é]